Previous Article | Next Article ![]()
Journal of Virology, March 2000, p. 2620-2627, Vol. 74, No. 6
Department of Neuropharmacology, The Scripps
Research Institute, La Jolla, California 92037
Received 9 August 1999/Accepted 17 December 1999
Virus infections are devastating to neonates, and the induction of
active antiviral immunity in this age group is an important goal. Here,
we show that a single neonatal DNA vaccination induces cellular and
humoral immune responses which are maintained for a significant part of
the animal's life span. We employ a sensitive technique which permits
the first demonstration and quantitation, directly ex vivo, of
virus-specific CD8+ T cells induced by DNA immunization.
One year postvaccination, antigen-specific CD8+ T cells
were readily detectable and constituted 0.5 to 1% of all
CD8+ T cells. By several criteria
0022-538X/00/$04.00+0
Copyright © 2000, American Society for Microbiology. All rights reserved.
Immune Responses following Neonatal DNA Vaccination
Are Long-Lived, Abundant, and Qualitatively Similar to Those Induced by
Conventional Immunization
including cytokine
production, perforin content, development of lytic ability, and
protective capacity
DNA vaccine-induced CD8+ memory T
cells were indistinguishable from memory cells induced by immunization
with a conventional (live-virus) vaccine. Analyses of long-term humoral
immune responses revealed that, in contrast to the strong
immunoglobulin G2a (IgG2a) skewing of the humoral response seen after
conventional vaccination, IgG1 and IgG2a levels were similar in
DNA-vaccinated neonatal and adult animals, indicating a balanced T
helper response. Collectively, these results show that a single DNA
vaccination within hours or days of birth can induce long-lasting
CD8+ T- and B-cell responses; there is no need for
secondary immunization (boosting). Furthermore, the observed immune
responses induced in neonates and in adults are indistinguishable by
several criteria, including protection against virus challenge.
*
Corresponding author. Mailing address: Department of
Neuropharmacology, CVN-9, The Scripps Research Institute, 10550 N. Torrey Pines Rd., La Jolla, CA 92037. Phone: (858) 784-7090. Fax: (858) 784-7380. E-mail: lwhitton{at}scripps.edu.
Manuscript 12423 of the Scripps Research Institute.
This article has been cited by other articles:
| J. Bacteriol. | Mol. Cell. Biol. | Microbiol. Mol. Biol. Rev. |
|---|
| Clin. Vaccine Immunol. | ALL ASM JOURNALS |
|---|